Ocular gels or hydrogels and microinjectors

Patent metadata

Field	Value
Publication number	US-2016106587-A1
Application number	US-201514878243-A
Country	US
Kind code	A1
Filing date	Oct 8, 2015
Priority date	Oct 16, 2014
Publication date	Apr 21, 2016
Grant date	—

Abstract

Devices and materials for treating an ophthalmic pathology affecting an eye of a patient comprising forming, in situ, a continuous cohesive layer of covalently-crosslinked hydrogel at a choroid in the eye, wherein the hydrogel comprises a therapeutic agent that is released into the eye to treat the ophthalmic pathology. An injection device for injection into a tissue, for example an eye, comprising a syringe, and a needle, with the syringe comprising a reservoir in fluid communication with an outlet and a piston for expelling contents of the reservoir from the syringe through the outlet. An embodiment provides for setting or using a force for moving the piston so as to deliver the contents at, for instance, a suprachoroidal location.

First claim

1 . An injection device comprising a syringe and a needle, with the syringe comprising a reservoir in fluid communication with an outlet and a piston for expelling contents of the reservoir from the syringe through the outlet.

2 . The device of claim 1 wherein the reservoir, before use, comprises a fluent material at a pressure that is less than a pressure required to inject the fluid from the syringe into a sclera and is at least equal to a pressure required to inject the fluid at a choroid.

3 . The device of claim 1 further comprising a biasing member that provides the piston force to the piston.

4 . The device of claim 1 wherein a piston force applied to the piston is greater than a force required to move the needle through a sclera and, while the piston force is applied at the piston, the reservoir has a pressure that is less than a pressure required to inject a fluid from the syringe into a sclera and is at least equal to a pressure required to inject a fluid at a choroid.

5 . The device of claim 1 wherein the needle has a distal tip and comprises a portion that is a biasing member set to deliver a constant force at the distal tip, set to compress when a certain threshold of force is applied at the needle tip, or set to provide an increasing amount of force as compression of the bias member is increased in response to a force applied at the distal tip.

6 . The device of claim 1 wherein the needle has a distal tip and comprising a plunger connected to the piston, wherein the plunger comprises a portion that is a biasing member.

7 . The device of claim 6 wherein the biasing member is set to deliver a constant force at the distal tip, to compress when a certain threshold of force is applied to the distal tip, or to provide an increasing amount of force as compression of the biasing member is increased in response to a force applied at the distal tip.

8 . The device of claim 1 wherein the needle is movable relative to the syringe.

9 . The device of claim 8 wherein the needle is connected to a biasing member, a spring bias member or a dashpot to control movement of the needle.

10 . The device of claim 1 wherein a variable force applied to the device is translated into a constant force at the needle.

11 . The device of claim 10 wherein a biasing member, a dashpot, a spring bias member, a spring, an extendible spring, a compressible spring, a permanently compressible member, or a reversibly compressible member translates the variable force into the constant force.

12 . The device of claim 1 further comprising, in the reservoir, a precursor to form a hydrogel in situ.

13 . A method of treating an ophthalmic pathology affecting an eye of a patient comprising forming, in situ, a continuous cohesive layer of covalently-crosslinked hydrogel at a choroid in the eye, wherein the hydrogel comprises a therapeutic agent that is released into the eye to treat the ophthalmic pathology.

14 . The method of claim 13 comprising introducing a hydrogel precursor in aqueous solution at the choroid that flows from the site and reacts to form the hydrogel.

15 . The method of claim 14 wherein the precursor is a first precursor, further comprising a second precursor in the aqueous solution, with the first precursor and second precursor crosslinking with each other to form the hydrogel.

16 . A method of injecting a fluent material at a choroid of an eye comprising
providing an injection device comprising a syringe and a needle, with the syringe comprising a reservoir in fluid communication with an outlet and a piston for expelling contents of the reservoir from the syringe through the outlet, forcing the needle into the eye to advance the needle through the sclera,
wherein a force applied to move the needle applies a piston force to the piston is greater than a force required to move the needle through the sclera and, while the piston force is applied at the piston, the reservoir has a pressure that is less than a pressure required to inject a fluid from the syringe into a sclera and is at least equal to a pressure required to inject a fluid at a choroid, and
stopping the advancement of the needle through the sclera when the fluent material leaves the needle, with the needle being at the choroid.

17 . A method of injecting a fluent material at a choroid of an eye comprising
providing an injection device comprising a syringe and a needle, with the syringe comprising a reservoir in fluid communication with an outlet and a piston for expelling contents of the reservoir from the syringe through the outlet, wherein the reservoir, before use, comprises the fluent material at a pressure that is less than a pressure required to inject the fluent material from the syringe into a sclera and is at least equal to a pressure required to inject the fluid at a choroid, forcing the needle into the eye through the sclera until the needle is at the choroid, and allowing the pressure of the reservoir to move the fluent material into the eye at the choroid.

18 . A method of injecting a fluent material at a choroid of an eye comprising
providing an injection device comprising a syringe and a needle, with the syringe comprising a reservoir in fluid communication with an outlet and a piston for expelling contents of the reservoir from the syringe through the outlet, the device further comprising a biasing member connected with the needle or a plunger, said plunger being connected to the piston, applying a force to the device to advance the needle into the eye through the sclera, with the biasing member translating variations in the force into a constant force.

19 . The method of claim 18 wherein the biasing member is set to compress when a certain threshold of force is applied at the needle tip.

20 . A double reservoir syringe and a needle, with the syringe comprising a first barrel serving as a reservoir in fluid communication with an outlet and a piston for expelling contents of the reservoir from the syringe through the outlet and a second barrel comprising a biasing member, and
applying a force to the device to advance the needle into the tissue, with the biasing member providing a resistance to a distal movement of the device.

Assignees

• Incept Llc

Inventors

• Jarrett Peter
• Mcgrath Michael J
• El-Hayek Rami
• Sawhney Amarpreet S

Classifications

• A61K9/0048 Primary

  Eye, e.g. artificial tears · CPC title

• A61K9/06

  Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)} · CPC title

• A61M5/19

  having more than one chamber {, e.g. including a manifold coupling two parallelly aligned syringes through separate channels to a common discharge assembly (surgical glue applicators A61B17/00491)} · CPC title

• A61F9/0026 Primary

  Ophthalmic product dispenser attachments to facilitate positioning near the eye · CPC title

• A61K31/573

  substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone · CPC title